View on Pubmed.gov 37655441 | View on doi.org 10.1080/1949097...
The curious case of .
- Biomedical Sciences, Zewail City of Science and Technology, Giza, Egypt.
- Microbiology and Immunology Research Program, Children's Cancer Hospital Egypt 57357, Cairo, Egypt.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Center for Genome and Microbiome Research, Cairo University, Cairo, Egypt.
Abstract
is an abundant member of the human gastrointestinal microbiome, whose relative abundance has curiously been associated with positive and negative impacts on diseases, such as Parkinson's disease and rheumatoid arthritis. Yet, the verdict is still out on the definitive role of in human health, and on the effect of different diets on its relative abundance in the gut microbiome. The puzzling discrepancies among studies have only recently been attributed to the diversity of its strains, which substantially differ in their encoded metabolic patterns from the commonly used reference strain. However, such strain differences cannot be resolved by common 16S rRNA amplicon profiling methods. Here, we scrutinize , its versatile metabolic potential, and the hypotheses behind the conflicting observations on its association with diet and human health. We also provide suggestions for designing studies and bioinformatics pipelines to better research .
References
Oncotarget. 2015 Oct 20;6(32):33689-704
Front Cell Infect Microbiol. 2020 Apr 09;10:151
Clin Dev Immunol. 2013;2013:419357
PLoS One. 2013 Aug 06;8(8):e70803
Cited by 50 citations (total)
Journal Article
Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivors.
Electronic publication date October 30, 2024
Xinyu Liu [...] Jingnan Li et al.
BACKGROUND
The influence of the gut microbiota on long-term immune checkpoint inhibitor (ICI) efficacy and immune-related adverse events (irAEs) is poorly...
Case Reports
Case report: Primary CDK4/6 inhibitor and endocrine therapy in locally advanced breast cancer and its effect on gut and intratumoral microbiota.
Electronic publication date April 11, 2024
Guilherme Vilhais [...] Ana Faria et al.
Locally advanced breast cancer poses significant challenges to the multidisciplinary team, in particular with hormone receptor (HR) positive, HER2-negative tumors...
Conflict of interest statement
MeSH
- •
Specialties
- •
- •
- •
- •